Skip to content

Evidence used to support decisions must be broad-based. Regional immunization policy decisions have historically relied primarily on the burden of disease and vaccine efficacy; however, the higher cost of new vaccines will require a much broader evidence base ranging from cost effectiveness and financial sustainability to health systems concerns.

Last Updated on Thursday, 26 February 2009 09:37

Regional Office for the Americas of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

© Pan American Health Organization. All rights reserved.